This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (7)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Women's Health, Other  • Oncology  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Does Sex Matter?

Rita F. Redberg, MD, MSc

JAMA. 2005;294:107-109.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The critical importance of preventive medicine for all people has long been recognized, as documented in the writings of Hippocrates and Osler.¹ Moreover, in preventive health, it is clear that sex matters, as the 2001 Institute of Medicine report concluded after reviewing the basis for biological differences in health.²

The goal of preventing cardiovascular disease is similar in men and women. However, the strategies and recommendations to achieve this goal differ, as exemplified in the 2004 American Heart Association Guidelines for Cardiovascular Disease Prevention in Women.³ Although it is increasingly well known and appreciated that heart disease is the leading cause of death in both women and men, it is also true that researchers are increasingly discovering sex differences in how cardiovascular disease may be prevented and treated.

All prevention, as well as treatment, involves some degree of balancing benefit and risk. The attractiveness of . . . [Full Text of this Article]

Author Affiliation: Division of Cardiology, University of California, San Francisco.

RELATED ARTICLE

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial
I-Min Lee, Nancy R. Cook, J. Michael Gaziano, David Gordon, Paul M Ridker, JoAnn E. Manson, Charles H. Hennekens, and Julie E. Buring
JAMA. 2005;294(1):56-65.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dual Therapy With Statins and Antioxidants Is Superior to Statins Alone in Decreasing the Risk of Cardiovascular Disease in a Subgroup of Middle-Aged Individuals With Both Diabetes Mellitus and the Haptoglobin 2-2 Genotype
Blum et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:e18-e20.
FULL TEXT  

Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial
Milman et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:341-347.
ABSTRACT | FULL TEXT  

Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect
Brookhart et al.
Am J Epidemiol 2007;166:348-354.
ABSTRACT | FULL TEXT  

Haptoglobin Genotype Determines Myocardial Infarct Size in Diabetic Mice
Blum et al.
J Am Coll Cardiol 2007;49:82-87.
ABSTRACT | FULL TEXT  

Research on Women's Health: Progress and Opportunities
Pinn
JAMA 2005;294:1407-1410.
FULL TEXT  

New Women's Health Study Data on Vitamin E and Aspirin
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT